The new Tufts Center for Integrated Management of Antimicrobial Resistance (CIMAR) is tackling one of the biggest global health concerns. By capitalizing on the existing strengths of Tufts schools and Tufts Medical Center and tapping faculty already working in the field from across the university, CIMAR is poised to become an internationally recognized center and trailblazer in AMR management.
Tufts researchers are developing a treatment to prevent the spread of cholera using bacteriophages—viruses that kill the cholera bacteria. Cholera is prevalent in regions with inadequate access to clean water and sanitation, striking almost 3 million people each year worldwide, and kills 95,000.
Phil Haydon was just fifteen years old when he suffered a severe brain injury that resulted in post-traumatic epilepsy. Today he’s the Chair of Tufts School of Medicine’s Department of Neuroscience, and in November of 2021 he plans to set sail from Boston and circumnavigate the globe on a fifty-foot yacht to raise awareness and money for epilepsy research.
-
A new study finds that two-father families still face discrimination, especially in states and settings that offer fewer legal and social protections.
-
Two Tufts alumni contributed to research providing a critical clue into the mysterious cause of the deadliest Ebola outbreak in history
-
Researchers from the School of Medicine and the School of Engineering are investigating ways to improve indoor air quality in multifamily housing built near major roadways and highways.
-
Tufts Now recently spoke to Carol Kumamoto, a microbiologist at Tufts School of Medicine, about her research on C. albicans and some of the surprising implications that this work has for understanding the balances of bacteria and fungi in our guts.
-
New narrowly focused approach shows how long-range connections between nerve cells lock brain plasticity into place; could advance treatments for disorders such as autism